AbCellera Biologics (ABCL) Long-Term Debt Repayments (2020 - 2021)
AbCellera Biologics' (ABCL) quarterly Long-Term Debt Repayments came in at $107000.0 in Q2 2021, up 272.58% YoY from $28718.6 in Q2 2020, and down 93.76% on a QoQ basis from $1.7 million in Q1 2021.
AbCellera Biologics (ABCL) Long-Term Debt Repayments (2020 - 2021) Analysis & Trends
AbCellera Biologics (ABCL) has 2 years of Long-Term Debt Repayments data on file, last reported at $107000.0 in Q2 2021.
- Quarterly Long-Term Debt Repayments rose 272.58% year-over-year to $107000.0 in Q2 2021, while the trailing twelve-month figure through Dec 2021 was $1.8 million (down 90.86% YoY) and the FY2021 annual result came in at $1.8 million, down 90.86% from the prior year.
- Long-Term Debt Repayments eased to $107000.0 in Q2 2021, from $1.7 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $15.0 million in Q3 2020 to a low of -$62000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 17.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 107,000.00 |
| Jun 30, 2021 | 107,000.00 |
| Mar 31, 2021 | 1.72 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Sep 30, 2020 | 15.00 Mn |
| Sep 30, 2020 | 15.00 Mn |
| Jun 30, 2020 | -62,000.00 |
| Jun 30, 2020 | -62,000.00 |
| Mar 31, 2020 | 2.03 Mn |
| Mar 31, 2020 | 2.03 Mn |